The airline industry is known for being highly competitive, with fuel prices exposure, high customer power, and sector overcrowding driving downward pressure on margins as well as shareholder returns. Airlines are also extremely capital-intensive and require large amounts of debt…
In previous posts, I shared some data on the root cause of Reddit’s substantial user growth over the past few quarters: Google. Reddit’s partnership with Google is worth closer to $50M per quarter rather than the reported $15M. More specifically,…
Ever since covid Era Peloton Interative (PTON) stock has been in free fall, to the tune of liquidating the former CEO and hammering his net worth from billions to <$100m. Touted as just a bike with an Ipad the bear…
I am going to start this DD off with a few concessions right off the bat. CHPT as a company has its risks for sure, quite a few at that. Their balance sheet is not the prettiest thing that you…
The primary factors driving this potential oil price increase include geopolitical tensions, production cuts by major oil-producing countries, and robust global demand. Ongoing conflicts in the Middle East, particularly the Israel-Hamas war, could lead to supply disruptions or fears of…
Coming live from the former prison colony known as Australia, bought and paid for by the mining companies pretending to be a nation, which somehow manages to have a better quality of life than Britain, despite our petarded politicians. I’d…
AST SpaceMobile (ASTS) has near-guaranteed upside in the long term, as long as they don’t freak up their technology completely. However, there are huge downsides over the next ~3 months, and these risks continue to grow every day. The upcoming…
Joby’s valuation is currently about 2.7x that of Archer Aviation (ACHR). After following both companies for some time now, Archer’s undervaluation is no longer deserved. I believe the key points below are a novel synthesis of the current state, front-running “official” announcements…
Cassava Sciences ($SAVA), a small clinical-stage biotech company, is focused on neurodegenerative diseases, with its lead asset, Simufilam, a small molecule pill undergoing pre-clinical and early clinical testing for Alzheimer’s disease. In our initial coverage of Cassava (SA, Nov. 2023), we…
First off, full transparency, I really like boats. Sections 0) BLUF: New congressional policies are going to make $HII go to the moon 🚢🚀🌕 Congress is probably about to funnel hundreds of billions of $$ into Huntington Ingalls and General…